Rubius Therapeutics Inc.

NASDAQ: RUBY · Real-Time Price · USD
0.06
0.00 (8.11%)
At close: Dec 29, 2023, 9:49 PM

Rubius Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-179.67M -214.55M -200.69M -206.63M -196.55M -182.06M -173.9M -161.57M
Depreciation & Amortization
6.25M 9.22M 7.87M 7.79M 7.72M 4.85M 5.14M 5.4M
Stock-Based Compensation
15.78M 26.28M 30.67M 35.23M 35.61M 35.37M 35.16M 33.82M
Other Working Capital
-7.71M 5.32M 1.7M 2.54M 836K 2.74M 4.39M -2.29M
Other Non-Cash Items
25.01M 18.35M 688K 766K 1.28M 1.15M 1.01M 955K
Deferred Income Tax
n/a n/a 8K 57K 118K 198K 279K 356K
Change in Working Capital
-17.52M 5.86M 8.37M 9.27M 6.69M 2.05M -231K -5.33M
Operating Cash Flow
-150.14M -154.84M -153.08M -153.52M -145.12M -138.45M -132.54M -126.37M
Capital Expenditures
-5.3M -6.41M -6.22M -5.3M -3.65M -3.31M -3.14M -3.39M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-83.63M -78.44M -78.44M -78.44M n/a 122.67M 57.47M 10M
Sales Maturities Of Investments
83.93M -6.25M -70M -42.5M n/a 132.5M 157.1M 166.1M
Other Investing Acitivies
17.94M 85M 85M 85M 85M -122.67M -122.67M -122.67M
Investing Cash Flow
12.94M -6.1M -69.67M -41.25M 81.35M 129.19M 88.75M 50.04M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-75.47M 648K 1.57M 4.62M 198.45M 198.11M 197.86M 219.91M
Financial Cash Flow
-75.47M 648K 1.57M 4.62M 198.45M 198.11M 197.86M 219.91M
Net Cash Flow
-212.67M -160.3M -221.19M -190.15M 134.68M 188.84M 154.07M 143.57M
Free Cash Flow
-155.45M -161.25M -159.31M -158.82M -148.77M -141.76M -135.68M -129.77M